We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP20102
Abstract: High throughput screening (HTS) is an expensive part of the drug development process. Increasing the efficiency and productivity of HTS is a key objective for today’s discovery organizations.
Predictive technology can be used to direct the screening of compounds prior to synthesis. However, issues such as the small proportion (usually less than 1%) of hits that occur in a given assay, complicate the application of statistical analysis and predictive modeling to this data.
What is required is an analysis technique that increases the significance of the data for the active compounds, while using all the information present in the original data set.Summary: High throughput screening (HTS) is an expensive part of the drug development process. Increasing the efficiency and productivity of HTS is a key objective for today’s discovery organizations. Predictive technology can be used to direct the screening of compounds prior to synthesis. However, issues such as the small proportion (usually less than 1%) of hits that occur in a given assay, complicate the application of statistical analysis and predictive modeling to this data.
Predictive technology can be used to direct the screening of compounds prior to synthesis. However, issues such as the small proportion (usually less than 1%) of hits that occur in a given assay, complicate the application of statistical analysis and predictive modeling to this data.
What is required is an analysis technique that increases the significance of the data for the active compounds, while using all the information present in the original data set.Summary: High throughput screening (HTS) is an expensive part of the drug development process. Increasing the efficiency and productivity of HTS is a key objective for today’s discovery organizations. Predictive technology can be used to direct the screening of compounds prior to synthesis. However, issues such as the small proportion (usually less than 1%) of hits that occur in a given assay, complicate the application of statistical analysis and predictive modeling to this data.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
DOSTARLIMAB : A BREAKTHROUGH IN THE FIELD OF CANCER
sriram Praveen*,G.mohana chari
Moxifloxacin Hydrochloride
Tylor
Tofacitinib Citrate
Tylor
Vertical phenotyper: small footprint device for high-throughput phenotyping of small plants and seedlings
Pavel Mazura, Pavel Klimeš, Lukáš Spíchal
RNA ISH
Hannah Cole
